A new study presented at the 3rd Congress of the European Academy of Neurology (EAN) and conducted by Dr. Maria Nicolodi from the Interuniversity Center in Florence has determined cannabis is more effective than traditional medications when it comes to treating the pain associated with migraines and cluster headaches. Researchers determined participants needed at least 100mg of a combination of THC and CBD before patients would experience any relief. For significant relief, patients received a dose of 200 mg. The amounts of THC and CBD varied. After determining the appropriate dose, researchers administered cannabis to one group, while the other group received antidepressants or blood pressure medications that are common for migraine and cluster headache therapies. Headache patients did not experience significant relief. Migraine sufferers, on the other hand, experienced a 43.5% reduction in pain. Side effects were considered minor and less severe than those experienced from prescription medications.
Dr. Nicolodi says of the study, “We were able to demonstrate that cannabinoids are an alternative to established treatments in migraine prevention. That said, they are only suited for use in the acute treatment of cluster headaches in patients with a history of migraine from childhood on.”
This information has been provided by MassRoots and approved by our Chief Medical Officer.